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A B S T R A C T
With the use of genetic technology, researchers have the potential to inform medical diagnoses and treatment in actionable ways. Accurate variant interpretation is a
necessary condition for the utility of genetic technology to unfold. This relies on the ability to access large genomic datasets so that comparisons can be made between
variants of interest. This can only be successful if DNA and medical data are donated by large numbers of people to ‘research’, including clinical, non-proﬁt and for-
proﬁt research initiatives, in order to be accessed by scientists and clinicians worldwide.
The objective of the ‘Your DNA, Your Say’ global survey is to explore public attitudes, values and opinions towards willingness to donate and concerns regarding
the donation of one's personal data for use by others. Using a representative sample of 8967 English-speaking publics from the UK, the USA, Canada and Australia, we
explore the characteristics of people who are unwilling (n=1426) to donate their DNA and medical information, together with an exploration of their reasons.
Understanding this perspective is important for making sense of the interaction between science and society. It also helps to focus engagement initiatives on the issues
of concern to some publics.
1. Introduction
1.1. Large genomic datasets underpin genomic medicine
In order to fully realise the potential of genomic medicine to predict,
diagnose, manage and treat genetic disease, clinical scientists routinely
access de-identiﬁed genomic datasets containing DNA and medical in-
formation from large numbers of people. Projects such as the Million
European Genomes Alliance plan to link electronic patient records with
genomic sequencing results from 1 million people across Europe in
order to meet this need for very large datasets with both genotype and
phenotype information (European Commission, 2018).
There has been wide support (Boycott et al., 2017; Budin-Ljosne
et al., 2014) for genomic data sharing, together with a call for practical
and ethical solutions to connect genomic databases and make them
more accessible for clinical and research purposes (Thompson et al.,
2014). Such health-related data are sensitive and may be potentially
misused (e.g. discrimination) or used in ways not supported by the data
contributors (Sterckx et al., 2016). Consequently, scholars have called
for consistent ethical and legal frameworks that enable access across
institutional and national jurisdictions that respect and protect in-
dividuals who have contributed data (Knoppers et al., 2014; Borry
et al., 2018). Such regulatory frameworks in turn aim to meet the needs
of people who currently refuse to participate in genetic research out of
fear for genetic discrimination (Wauters and Van Hoyweghen, 2016).
To determine whether a variant is consistently linked to a particular
phenotype, datasets should ideally contain information from people of
varying ages, disease status, health and ethnicity. However, many
https://doi.org/10.1016/j.ejmg.2018.11.014
Received 5 October 2018; Received in revised form 20 November 2018; Accepted 22 November 2018
∗ Corresponding author. Society and Ethics Research, Connecting Science, Wellcome Genome Campus, Cambridge, UK.
E-mail address: am33@sanger.ac.uk (A. Middleton).
European Journal of Medical Genetics xxx (xxxx) xxx–xxx
1769-7212/ © 2018 The Authors. Published by Elsevier Masson SAS. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
Please cite this article as: Middleton, A., European Journal of Medical Genetics, https://doi.org/10.1016/j.ejmg.2018.11.014
existing genomic databases have limitations in terms of the population
they represent, with the vast majority of studies focussed primarily on
European populations (Popejoy and Fullerton, 2016; Landry et al.,
2018). In order to meet the demand for larger numbers and more di-
versity, millions of people globally will need to donate and share their
data (Middleton, 2018; Birney et al., 2017). There have thus been calls
to encourage the donation of data which includes a broader population
as well as disease status, in order to support the equitable delivery of
genomic medicine (Sirisena and Dissanayake, 2017).
In this manuscript, we use the term ‘data donation’ to refer to the
decision an individual makes to contribute their genomic data to a
database that can be accessed by researchers or clinicians. The act of
‘data donation’ assumes that these data will be subsequently accessed
by and shared with others for clinical and research purposes.
Opportunities to donate DNA and/or medical data arise when in-
dividuals undergo genetic testing (Wright et al., 2017), store samples in
biobanks (Small, O'Donnell, and Damrauer, 2018), participate in clin-
ical research (Auﬀray et al., 2016) or when they donate their blood to
blood banks (Hartling et al., 2015). Understanding what motivates and
de-motivates data donation is pivotal to creating appropriately de-
signed engagement, dialogue strategies and regulatory frameworks
about genomic medicine and research.
1.2. Attitudes towards data donation
Empirical research on public attitudes to data sharing tells us that,
broadly speaking, publics are willing to donate and share their health
data with researchers (Weitzman et al., 2012). One driver of this is the
perceived use of data and expectations of data users, as many partici-
pants see their contribution to research as helping towards the ‘public
good’ (Dixon-Woods and Tarrant, 2009). In contrast, participants' view
of data donation becomes less positive when they are not consulted on
the uses of their data (McCormack et al., 2016) or believe that their
donation will primarily lead to big proﬁts for commercial companies,
without creating obvious public value (Trinidad et al., 2010). Research
from Wellcome has shown participation in research and data sharing
are viewed as more acceptable when care and attention is paid to ex-
plaining the necessary partnerships between industry and healthcare
(Wellcome , 2016). In addition, previous survey research, primarily in
the USA, has suggested that there may be important diﬀerences in the
characteristics of those willing to donate their genomic data to re-
search, particularly associated with education, race, religiosity and le-
vels of perceived beneﬁt and concern (Sanderson et al., 2017; Shabani
et al., 2014).
In this paper, we focus on the characteristics and reasoning of
people who are unwilling to donate their DNA and medical data to
research using ﬁndings from the ‘Your DNA, Your Say’ international
survey. The ‘Your DNA, Your Say’ survey is part of a global project that
has been translated into several languages, including: Russian, Polish,
Portuguese, Spanish, German, Icelandic, Swedish, French, Japanese,
Urdu, Arabic, and Italian with plans to translate into Hindi, Mandarin,
Zulu, Twi and Ewe. Once global recruitment is completed, we will
perform a between-country meta-analysis of attitudes, which will be
described separately. Here we present here data from the English-
speaking participants (for whom recruitment has ﬁnished). The survey
was developed in collaboration with the Participant Values task team of
the Global Alliance for Genomics and Health, a public-private con-
sortium developing policy frames and technical standards for the ex-
change of genomic and health-related data.
2. Methods
A more detailed description of the methodological rationale for the
study, design (and limitations), recruitment strategy, and process of
data collection have been published separately (Middleton et al., 2018),
as has a review of the context and background to this project
(Middleton, 2018).
2.1. Sample
Using a market research company, ResearchNow, we collected
completed surveys from publics in the USA, Canada, United Kingdom
(UK) and Australia (n=8967). Participants were paid a small ﬁnancial
reward (< £1) for participating and due to the nature of recruitment
there are no details on non-response rate. Our participant samples are
‘representative’, according to recent census data, of populations in
Canada, the USA, the UK and Australia in terms of age and gender.
However, as we did not speciﬁcally aim to recruit a ‘representative’
sample according to self-reported ethnicity, the ethnic diversity of our
sample cannot be considered ‘ethnically representative’. We found only
small variation in between-country analysis and have corrected for this
in the modelling; thus, in this paper we have chosen not to focus spe-
ciﬁcally on diﬀerences between participant attitudes from the UK, the
USA, Canada, and Australia but to explore the collective proﬁles of
those participants, across countries.
2.2. Measures
Our cross-sectional, exploratory online survey can be accessed from
www.YourDNAYourSay.org. It contains 29 questions and piloting
showed it took approximately 15–20min to complete.
2.2.1. Donating DNA and medical information
Throughout the survey, participants were asked whether they would
donate their “anonymous''1 DNA and medical information for use by
others in research. We asked participants to distinguish who they would
allow to use their data, (a) medical doctors; (b) non-proﬁt researchers;
(c) for-proﬁt researchers. Participants were classiﬁed as willing to donate
if they answered “yes” to at least one of these questions, unwilling to
donate if they answered “no” to all three, and unsure if they answered
“unsure” to all three. We will publish separately on the proﬁle of those
who were more accepting of data donation (Middleton et al., under
review) and on the distinctions participants make between users of
their data.
2.2.2. Sociodemographics
Age was collected in ten-year categories from age 16 onwards, but
due to the lower number of responses in younger and older age cate-
gories these were collapsed into three categories of “30 years and
under”, “31–50“, and “51 years and older'' for analysis. Whether par-
ticipants had children was determined by a “Yes'' or “No'' answer
without specifying whether the children were biological or not.
Relationship status was collected as “Divorced'', “Separated'', “Single'',
“Widowed'', “Married/civil partnership/living together'', but all cate-
gories apart from the latter were collapsed for analyses.
We piloted how best to collect ethnicity data, starting with the ca-
tegories provided in the UK Census survey and adapting these, based on
feedback from pilot participants involved in survey development. The
resultant ethnicity question in the ﬁnal survey thus asked participants
to self-identify as (1) White, (2) Afro-European/African American,
1Within the survey glossary we explained ‘anonymous’ in more detail:
‘Anonymous: removal of personal information such as name and date of birth. It
is questionable as to whether DNA information can ever be truly anonymous as
our DNA code is unique to us and thus, in itself, could be used to identify us.
However, in the circumstances we are exploring here, by making DNA and
medical information 'anonymous', we mean detaching personal identiﬁers from
it.’ What we are actually meaning here is ‘de-identiﬁed’ but within the pilot
work for the survey we discovered that public participants did not naturally
understand this term and ‘anonymous’ was more easily understood, thus we
added the glossary deﬁnition within the survey itself, to explain this in more
detail.
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Black (3) Hispanic (4) South Asian, Indian, Pakistani (5) East Asian
Chinese, Japanese (6) Arabic, Central Asian (7) Other (Table 1). Par-
ticipants could also choose not to answer this question at all. In the
analysis, due to the low number of participants who self-identiﬁed as a
member of a group other than “White” (less than 10% of the sample for
each country), these were collapsed into a single “Non-White” category
for analysis. Highest level of education was categorised as “Tertiary'',
“Secondary'', “Primary'' or “Other'' based on structured responses and
also free-text descriptions of educational qualiﬁcations. This was col-
lapsed to a binary indicator of tertiary education for multivariable
analyses. Religiosity was determined by participant response to the
question “Independent of whether you attend religious services or not,
would you say you are … ?'' with options “A religious person'' or “Not a
religious person''.
2.2.3. Genetics experience
Genetics experience was derived from two variables: “Are you fa-
miliar with DNA, genetics, or genomics?'' If a respondent chose the
answer: “I'm familiar through my work, personal interests or family/
medical history'', they could further specify. Participants were cate-
gorised as having “Personal'' experience of genetics if they said they
were familiar with DNA/genetics/genomics and that familiarity was
due to either having a genetic condition in their family, or through their
work (e.g. genetic health professional or genetic researcher).
Participants without this experience were categorised as “Familiar'' or
“Unfamiliar'' based on their response to the ﬁrst question.
2.2.4. Potential for harm
Participants were asked a single question regarding harms asso-
ciated with linking personally identifying information to their DNA
data: “If someone linked your name, address and phone number to it,
do you think you could be harmed in any way from this?'' Response
options were “Yes'', “No'', “I'm not sure'' with the latter two categories
collapsed for analysis.
2.2.5. Concerns about speciﬁc harms
Participants were presented with a list of hypothetical harms that
could occur in relation to DNA information and asked to indicate which
three of these concerned them the most. The list of hypothetical harms
was based on pilot work, the academic literature and experience of the
authors who designed the survey. The list of hypothetical harms pre-
sented to participants was:
• My friends potentially knowing something about me that I hadn't
chosen to tell them
• My family potentially knowing something about me that I hadn't
chosen to tell them
• My government potentially knowing something about me that I
hadn't chosen to tell them
• Police potentially knowing something about me that I hadn't chosen
to tell them
• Marketing companies targeting me to sell me products
• Being stigmatised and labelled in some way online
Table 1
Sample description (n= 8961). Participants willing, unwilling and unsure about donating DNA and/or medical information to research (including to medical
doctors, non-proﬁt and for-proﬁt researchers) associated with familiarity about genetics and demographic variables. P-values for χ2 tests (excluding missing data) are
shown.
Variable Categories Total (n=8961) Willing (n=6073) Unwilling (n= 1426) Unsure (n= 1462) P
N % N % N % N %
Genetics knowledge Unfamiliar 5004 55.8 3036 50 918 64.4 1050 71.8 < 0.0001
Familiar 2786 31.1 2052 33.8 407 28.5 327 22.4
Personal 1170 13.1 985 16.2 100 7 85 5.8
Missing 1 0 0 0 1 0.1 0 0
Age 30 and under 2090 23.3 1493 24.6 270 18.9 327 22.4 < 0.0001
31–40 2046 22.8 1406 23.2 310 21.7 330 22.6
41–50 1569 17.5 988 16.3 272 19.1 309 21.1
51–60 1588 17.7 1011 16.6 297 20.8 280 19.2
Over 60 1664 18.6 1172 19.3 277 19.4 215 14.7
Missing 4 0 3 0 0 0 1 0.1
Gender Female 4328 48.3 2895 47.7 631 44.2 802 54.9 < 0.0001
Male 4573 51 3154 51.9 780 54.7 639 43.7
Missing 60 0.7 24 0.4 15 1.1 21 1.4
Children No 3695 41.2 2445 40.3 641 45 609 41.7 0.001
Yes 5111 57 3556 58.6 743 52.1 812 55.5
Missing 155 1.7 72 1.2 42 2.9 41 2.8
Education Tertiary 5172 57.7 3664 60.3 759 53.2 749 51.2 < 0.0001
Secondary 3009 33.6 1943 32 520 36.5 546 37.3
Primary 551 6.1 331 5.5 103 7.2 117 8
Other 224 2.5 131 2.2 44 3.1 49 3.4
Missing 5 0.1 4 0.1 0 0 1 0.1
Country United Kingdom 3316 37 2257 37.2 486 34.1 573 39.2 0.006
United States 1992 22.2 1366 22.5 334 23.4 292 20
Canada 2251 25.1 1544 25.4 349 24.5 358 24.5
Australia 1402 15.6 906 14.9 257 18 239 16.3
Ethnicity Afro-European, African American, Black 322 3.6 211 3.5 56 3.9 55 3.8 0.088
Asian 660 7.4 422 6.9 117 8.2 121 8.3
Hispanic 139 1.6 85 1.4 27 1.9 27 1.8
Other 193 2.2 121 2 36 2.5 36 2.5
White 7538 84.1 5186 85.4 1150 80.6 1202 82.2
Missing 109 1.2 48 0.8 40 2.8 21 1.4
Religiosity Not a religious person 5608 62.6 3695 60.8 923 64.7 990 67.7 < 0.0001
A religious person 3348 37.4 2374 39.1 503 35.3 471 32.2
Missing 5 0.1 4 0.1 0 0 1 0.1
Relationship Married/civil partnership/living together 5564 62.1 3847 63.3 829 58.1 888 60.7 0.001
Divorced/Single/Widowed 3392 37.9 2222 36.6 597 41.9 573 39.2
Missing 5 0.1 4 0.1 0 0 1 0.1
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• Being cloned
• My DNA being copied and then planted at the scene of a crime
• Health or life insurance companies using the information to dis-
criminate against me
• Employers using the information to discriminate against me
• Upsetting my genetic relatives
• Ethnic identiﬁcation and racial discrimination
2.2.6. Factors aﬀecting the decision to donate
Participants were asked to identify what factors would inﬂuence
their decision to donate their DNA and medical information. They were
asked to select from the following list (multiple selections possible):
• Whether my identifying information (age, sex, etc.) will be included
or not
• Who has control over access to my information
• What sorts of research my information could be used in
• The potential risks and beneﬁts of making a donation
• How the researcher might beneﬁt from accessing my information
• What sort of researchers are likely to access my information
• How I might be acknowledged for my contribution to scientiﬁc
knowledge
• If the researchers were going to make money with the results
• Whether I would have access to the DNA readout generated by re-
searchers
• If I can participate in the governance of data access
• How I will be assisted if there is a data breach
2.3. Statistical analysis
Sample characteristics were summarised using standard descriptive
statistics, and bivariate relationships were evaluated using χ2 tests as
all variables were categorical. Importance of p-values was considered in
the context of multiple testing. The multivariable analysis of participant
characteristics associated with donation preference was conducted
using a multinomial logistic regression model with donation preference
as the outcome variable. A complete-case sample was used. We have
previously used multi-level models to analyse these data (Middleton
et al., under review) but comparison of model ﬁt showed that a multi-
level model was not necessary for donation preference. Familiarity with
genetics, age, gender, ethnicity, country of residence, marital status,
having children, education level, and religiosity were included as cov-
ariates. As this model was explanatory rather than predictive, no vari-
able selection methods were used and the full model is presented.
3. Results
3.1. Attitudes towards donation
In this sample, 15.9% of participants (n= 1426) reported that they
were unwilling to donate their DNA and medical information to med-
ical doctors, non-proﬁt researchers, or for-proﬁt researchers (with the
explained assumption that these professionals would then access and
share this data with others in their speciﬁc ﬁeld). A further 16.3%
(n=1462) were unsure in all cases. The majority (67.7%; n=6073)
were willing to donate in at least one scenario (this latter group are
explored in more depth elsewhere, Middleton et al., under review).
Data on this topic were missing for 6 participants, who were excluded
from further analyses.
Compared to those who were willing to donate (Table 2), those who
were unsure or unwilling had substantially lower odds of being familiar
with, or having a personal experience of, genetics/genomics. Both of
these groups also had lower odds of being aged 30 and under, and
higher odds of not having a tertiary-level qualiﬁcation and of self-
identifying as a member of an ethnic group other than White.
Table 2 also shows people who were unwilling to donate had a
diﬀerent sociodemographic proﬁle than those who were unsure. Spe-
ciﬁcally, those unwilling and unsure about donating diﬀered in relation
to gender, having children, country of residence, and religiosity.
Compared to those who were willing to donate, those who were unsure
had much lower odds of being male (odds ratio (OR) 0.74; 95% con-
ﬁdence interval (CI) 0.66–0.84; p < 0.0001) whereas there was no
gender diﬀerence between those who were and were not willing to
donate. There was no diﬀerence between those people who were
willing to donate and those who were unsure in terms of having chil-
dren or country of residence, but these factors were strongly associated
with being unwilling to donate; unwilling participants had much lower
odds of having children (OR 0.74; 95%CI 0.65–0.84; p < 0.0001), and
greater odds of residing in the USA or Australia (OR 1.37; 95%CI
1.15–1.62; p < 0.0001 and OR 1.28; 95%CI 1.07–1.53; p= 0.008 re-
spectively). Those unsure about donating had lower odds of being re-
ligious (OR 0.78; 95%CI 0.69–0.90; p=0.003), but there was no sub-
stantial diﬀerence between those who were and were not willing to
donate in terms of religiosity. Put simply, those who were unsure about
data donation were more likely to be female, to have children, and to
reside in the USA or Australia, but less likely to be religious than those
who were unwilling to donate data (both compared to those willing to
donate their data).
3.2. Perceptions of harms arising from linking personal and DNA/medical
information
A similar percentage of participants in the willing and unwilling to
donate groups (45.1% and 45.6% respectively) believed that linking
their DNA and medical information to their personal details could result
in personal harm, whereas only 27.8% of unsure participants agreed
with the statement (Table 3). This reﬂects the fact that those partici-
pants who were unsure overall were also more likely to be unsure about
the potential for data linkage to result in harm, and thus less likely to
agree with the statement.
The potential harm identiﬁed most frequently by participants was
“My DNA being copied and then planted at the scene of a crime”; 45%
of each group endorsed this (see Table 3; Fig. 1). The three groups were
also similar in terms of concern regarding family and friends knowing
something about them, and employers using the information to dis-
criminate against them. However, the three groups diﬀered in relation
to other concerns about potential harms. The other harms most fre-
quently endorsed by the willing-to-donate group were: “Health or life
insurance companies using the information to discriminate against me”
(39.2%) and “Marketing companies targeting me to sell products”
(36.7%).
The unwilling-to-donate group were also concerned about insurance
discrimination (33.7%), and marketing uses of data (30.7%). However,
they were more concerned about “My government potentially knowing
something about me that I hadn't chosen to tell them” (40.3%). This
was a higher percentage than those in the willing-to-donate and unsure
groups (30.5% and 31.1% respectively; χ2= 51.08; df= 2;
p < 0.0001). This group was also more likely to be concerned about
“Police potentially knowing something about me that I hadn't chosen to
tell them” (23.8% compared to 17% of the other groups; χ2= 35.53;
df= 2; p < 0.0001).
3.3. Factors inﬂuencing the decision to donate DNA/medical information
There were substantial diﬀerences between the three donation
groups for all the factors inﬂuencing donation that participants were
asked to explore (see Table 4; Fig. 2). However, the diﬀerences all
followed the same pattern: participants who were unwilling to donate
were proportionally less likely to identify a factor as inﬂuencing their
decision to donate than those who were willing to donate.
The factor that unwilling-to-donate participants most commonly
identiﬁed as inﬂuencing their decision to donate was the question of
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who would control access to their information (27%), followed by
whether identifying information would be included or not (24%).
Participants were least likely to be inﬂuenced in their decision by
whether they would be acknowledged for their contribution (10%) and
whether they would be able participate in the governance of data access
(11%).
4. Discussion
The focus of this paper is on the proﬁle and characteristics of those
participants who said they were unwilling to donate their DNA and
medical data to be shared in clinical and scientiﬁc research. Our results
show those members of the public who said they were unwilling to
donate their DNA and medical data had a broad demographic proﬁle.
They were more likely to be older (men or women), without children,
with lower levels of education, to be from the USA or Australia and to
have self-reported ethnicity as any of the groups other than White.
Along with those who were ‘unsure about donation’, those who were
unwilling to donate were a group with little reported familiarity with
DNA, genetics and genomics. The key question arising from the results
is why this particular proﬁle might be associated with being unwilling
to donate one's data.
A ﬁrst explanation would be that this group are more concerned
than others about the overall harms associated with re-identiﬁcation.
Our data suggests this is not the case. The proportion who thought it
was possible that they could be harmed was not greater amongst par-
ticipants unwilling to donate than among those who were willing.
Importantly, however, the types of concerns were diﬀerent amongst this
group. Speciﬁcally, in comparison with those who were willing to do-
nate, the unwilling group were more likely to say that they were wor-
ried about the government or police knowing something about them
that they had not chosen to share. They were less likely to identify
harms associated with insurance and marketing uses of data.
These data suggest that increasing familiarity with DNA, genetics
and genomics may not be enough to convert someone who is unwilling
about donation to someone more willing to donate. Familiarity is a key
diﬀerence between the otherwise similar proﬁles (in terms of all vari-
ables we measured) of those who are ‘unsure about donation’ and those
who are willing to donate. Consequently, increasing familiarity may
result in the current ‘unsures’ potentially converting to a ‘yes’ to do-
nation. However, we are less conﬁdent about this prediction for those
currently ‘unwilling to donate’. This group diﬀer across variables from
Table 2
Multinomial logistic regression result for views on donation, with willing to donate as reference category (n=8703), associated with familiarity about genetics and
demographic data. OR indicates odds ratio; LCI indicates lower 95% conﬁdence interval; UCI indicates upper 95% conﬁdence interval.
Variable Category Unwilling Unsure
OR LCI UCI P OR LCI UCI P
Genetics knowledge Unfamiliar ref. ref.
Familiar 0.66 0.58 0.76 <0.0001 0.5 0.43 0.58 < 0.0001
Personal 0.35 0.28 0.43 <0.0001 0.25 0.2 0.32 < 0.0001
Age Over 50 ref. ref.
31–50 0.93 0.81 1.07 0.34 1.2 1.04 1.38 0.01
30 and under 0.64 0.54 0.77 <0.0001 0.9 0.75 1.07 0.22
Gender Female ref. ref.
Male 1.12 0.99 1.27 0.06 0.74 0.66 0.84 < 0.0001
Children No ref. ref.
Yes 0.74 0.65 0.84 <0.0001 0.92 0.81 1.05 0.20
Tertiary education Yes ref. ref.
No 1.26 1.11 1.43 0.0003 1.31 1.16 1.49 < 0.0001
Country United Kingdom ref. ref.
United States 1.37 1.15 1.62 0.0003 1.08 0.91 1.29 0.36
Canada 1.09 0.93 1.28 0.29 1.08 0.92 1.27 0.33
Australia 1.28 1.07 1.53 0.008 1.09 0.91 1.3 0.34
Ethnicity White ref. ref.
Non-White 1.37 1.15 1.62 0.0004 1.35 1.14 1.61 0.0005
Religious person No ref. ref.
Yes 0.87 0.76 0.99 0.03 0.78 0.69 0.9 0.0003
Table 3
Numbers and percentages of participants in each donation group (i) agreeing that linkage of personal information to DNA could result in harm; (ii) endorsing
individual potential harms. P-values for χ2 tests are shown.
Variable Total Willing Unwilling Unsure P
N % N % N % N %
Agreement to “If someone linked your name, address and phone number to [your DNA], do you think you could be
harmed in any way from this?”
3816 42.6 2767 45.6 643 45.1 406 27.8 < 0.0001
My DNA being copied and then planted at the scene of a crime 4050 45.2 2741 45.1 645 45.2 664 45.4 0.981
My family potentially knowing something about me that I hadn't chosen to tell them 1871 20.9 1311 21.6 277 19.4 283 19.4 0.057
My friends potentially knowing something about me that I hadn't chosen to tell them 1981 22.1 1368 22.5 277 19.4 336 23 0.027
Employers using the information to discriminate against me 2131 23.8 1503 24.7 306 21.5 322 22 0.007
Health or life insurance companies using the information to discriminate against me 3333 37.2 2379 39.2 480 33.7 474 32.4 < 0.0001
Marketing companies targeting me to sell me products 3139 35 2230 36.7 438 30.7 471 32.2 < 0.0001
My government potentially knowing something about me that I hadn't chosen to tell them 2882 32.2 1853 30.5 574 40.3 455 31.1 < 0.0001
Police potentially knowing something about me that I hadn't chosen to tell them 1630 18.2 1042 17.2 339 23.8 249 17 <0.0001
Being stigmatised and labelled in some way online 1941 21.7 1362 22.4 257 18 322 22 0.001
Being cloned 2510 28 1556 25.6 453 31.8 501 34.3 < 0.0001
Upsetting my genetic relatives (because my DNA information is similar to their DNA information) 1306 14.6 809 13.3 218 15.3 279 19.1 < 0.0001
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those who are willing to donate, both in terms of the potential harms
they perceive and the factors which inﬂuence their decision to donate.
Rather than familiarity, a key feature of this group appears to be unease
with systems of legal and political authority, notably governments and
the police. This may explain the lack of success of legal controls in
limiting concerns about genetic discrimination (Wauters and Van
Hoyweghen, 2016) and suggests the potential limitations of approaches
to dialogue which do not take such concerns into account.
Whilst our research study did not set out to explore attitudes spe-
ciﬁcally from particular ethnic groups (although between-country at-
titudes will be explored) we have found that those who self-identify as a
member of an ethnic group other than White have higher odds of being
unwilling to donate their DNA or health data. The combination of
concerns about government and police use of data with potential ethnic
diﬀerences in the data echoes previous research which has reported
concern that genetic results could be used to racially discriminate
(Goldenberg et al., 2011). We all have, irrespective of our ethnic or
racial background, a right to protection against discrimination. How-
ever, fear of discrimination is very signiﬁcant for some (Wauters and
Van Hoyweghen, 2016). Ethnic minority groups including African
American/European Black and Asian groups have at times been re-
ported to have a diﬃcult relationship with genomics services (Mathew
et al., 2017), the reasons for which are complex. Within the context of
data donation for the assessment of disease risk (such as cancer) the
perception of stigma (the notion of being at risk) and taboo could
contribute to unwillingness to donate among ethnic minority groups
along with low level of knowledge and awareness of familial cancer risk
(Hann et al., 2017; Allford et al., 2014). Also, the aniticipated impact on
minority communities could explain reluctance to donate; such as the
stratiﬁcation of society into people with “good” and “bad” genes
leading to genomic medicine largely beneﬁting a privileged few
(Bentley et al., 2017). This literature emphasises the importance of
previous ethical injustices within medical research (Underwood et al.,
2013) and fears of discrimination (Buseh et al., 2013) which provide
potential causes for mistrust (Buseh et al., 2014) and fear (Catz et al.,
2005). Steps should be taken to acknowledge and address these very
real fears so as not to perpetuate perceptions of discrimination and
persecution; policy makers have begun to explore practical steps to do
this, including advocating the need for cultural literacy amongst ge-
neticists, and promotion of evidence based ethical engagement strate-
gies (Claw et al., 2018; Staunton et al., 2018).
Before deciding whether to oﬀer one's DNA and medical data to be
used in research, individuals would beneﬁt from access to clear in-
formation about the risks and beneﬁts, as well as details of the types of
research for which the data will be used. Research and clinical pro-
grammes need to be more transparent about how they collect, store,
process, and share data, as well as how they safeguard data against
potential breaches and how such breaches will be dealt with if they
occur. However, the practice of responsible genomic research also
needs be accompanied by a public dialogue about the implications of
genomic testing and the use of results. Even if we are not personally
undergoing genetic testing, it is increasingly possible that a biological
relative is, whether for clinical or research purposes or personal in-
terest. The decisions that our relatives make about whether to donate
their DNA and medical data for research are also relevant to us. Given
that all of us are likely to be confronted with the outcomes from
Fig. 1. Hypothetical harms arising from linking personally identiﬁable information (name, address etc) to DNA information. Participants were asked to rate if they
were concerned about these and then stratiﬁed according to willingness to donate DNA and/or medical data to research (including clinical, non-proﬁt, for-proﬁt
research).
Table 4
Numbers and percentages of participants in each donation group endorsing particular considerations regarding donation. P-values for χ2 tests are shown.
Variable Total Willing Unwilling Unsure P
N % N % N % N %
whether my identifying information 5076 56.6 4053 66.7 336 23.6 687 47 <0.0001
who has control over access to my information 5333 59.5 4224 69.6 386 27.1 723 49.5 < 0.0001
what sorts of research my information could be used in 4056 45.3 3159 52 303 21.2 594 40.6 < 0.0001
the potential risks and beneﬁts of making a donation 4110 45.9 3234 53.3 293 20.5 583 39.9 < 0.0001
how the researcher might beneﬁt from accessing my information 3378 37.7 2656 43.7 262 18.4 460 31.5 < 0.0001
what commercial proﬁts would be made on the basis of my information 3289 36.7 2605 42.9 237 16.6 447 30.6 < 0.0001
what sort of researchers are likely to access my information 3497 39 2748 45.2 253 17.7 496 33.9 < 0.0001
how I might be acknowledged for my contribution to scientiﬁc knowledge 1939 21.6 1494 24.6 143 10 302 20.7 < 0.0001
if the researchers were going to make money with the results 3126 34.9 2477 40.8 213 14.9 436 29.8 < 0.0001
whether I would have access to the DNA readout generated by researchers 3381 37.7 2711 44.6 218 15.3 452 30.9 < 0.0001
if I can participate in the governance of data access 2062 23 1600 26.3 160 11.2 302 20.7 < 0.0001
how I will be assisted if there is a data breach 3697 41.3 2951 48.6 240 16.8 506 34.6 < 0.0001
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genomic testing within our lifetimes, whether we interact with it as
citizens, patients or consumers (Roberts and Middleton, 2018) it is time
that the issues linked to genomic medicine are mainstreamed con-
versationally, or ‘socialised’ (Parry and Middleton 2017).
With more eﬀorts to familiarise publics with genomics, and greater
public dialogue about the pertinent issues, risks, and beneﬁts of data
donation and sharing, it is possible that those members of the publics
who are currently unsure about whether to donate, may make an in-
formed decision to participate. Equally, such dialogue should aim to
engage those who are currently unwilling to take part in genomic re-
search, perhaps through discussion of the principles and protections
which govern data use. Beneﬁting from the advances in science is a
fundamental human right that all of us have, irrespective of our eth-
nicity (Knoppers et al., 2014), and future public engagement ap-
proaches should consider how to engage with the mistrust reported by
certain publics, particularly those who do not self-identify as White.
The size of the sample analysed for this paper does not give us the
power to diﬀerentiate attitudes between the ethnic groups that are not
self-identiﬁed ethnically as White. As such, we have deliberately kept
our analysis broad. However, we believe that nuances in attitude re-
levant to ethnicity would beneﬁt from more research, perhaps using a
more subtle approach than an online survey can deliver. While this
survey has identiﬁed potential areas of concern, it is not possible to
draw out in greater detail the magnitude of the concerns identiﬁed; this
would be an important focus of future work. Finally, online surveys
have some important limitations, which we have discussed in detail in
the methods paper that accompanies our work (Middleton et al., 2018).
To understand in detail the reasons why diﬀerent groups of people are
more or less willing to donate or more or less trusting of diﬀerent re-
search/clinical programmes, there would be value in complementing
the current work with a deep qualitative approach.
5. Conclusion
To deliver genomic medicine at scale across the world, large data-
sets containing genomic and phenotypic data are required from millions
of people. These datasets are pivotal in variant interpretation to de-
termine whether a result in an individual has been seen frequently in
population studies before and whether it is known to be linked to dis-
ease. These datasets have traditionally been collected by researchers,
scientists and clinicians over the years as genomics has evolved. Yet,
fundamentally they rely on people agreeing to donate their data to be
used in this way.
The ‘Your DNA Your Say’ survey explores attitudes towards the
donation of one's own de-identiﬁed personal DNA and medical in-
formation to be accessed and shared for research.
In this paper we have reported the proﬁle of public participants
from the UK, the USA, Canada and Australia, who say they are un-
willing to donate their DNA and medical data. The ‘unwilling’ were
more likely to be older, of lower education background, childless, be
from the USA or Australia and to identify themselves as an ethnic
minority group that is not White. They were also more likely to express
concerns that were diﬀerent to those who were more enthusiastic about
data donation, more speciﬁcally, they were worried about governments
and police knowing information that they had not chosen to share.
These ﬁndings may reﬂect persistent concerns about discrimination and
persecution. In the future ethical and evidence-based public engage-
ment strategies should consider how to acknowledge and engage with
these fears and the cultural and political concerns which accompany
potential involvement in genomic research.
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